Cargando…
Blood Eosinophil Counts in Clinical Trials for Chronic Obstructive Pulmonary Disease
Autores principales: | Singh, Dave, Bafadhel, Mona, Brightling, Christopher E., Sciurba, Frank C., Curtis, Jeffrey L., Martinez, Fernando J., Pasquale, Cara B., Merrill, Debora D., Metzdorf, Norbert, Petruzzelli, Stefano, Tal-Singer, Ruth, Compton, Christopher, Rennard, Stephen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Thoracic Society
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7462391/ https://www.ncbi.nlm.nih.gov/pubmed/32186896 http://dx.doi.org/10.1164/rccm.201912-2384PP |
Ejemplares similares
-
Variability of blood eosinophil count and prognosis of COPD exacerbations
por: Martínez-Gestoso, Sandra, et al.
Publicado: (2021) -
Effect of inhaled corticosteroids on blood eosinophil count in steroid-naïve patients with COPD
por: Kreindler, James L, et al.
Publicado: (2016) -
Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key Changes
por: Reddel, Helen K., et al.
Publicado: (2021) -
Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary
por: Agustí, Alvar, et al.
Publicado: (2023) -
COPD exacerbation severity and frequency is associated with impaired macrophage efferocytosis of eosinophils
por: Eltboli, Osama, et al.
Publicado: (2014)